P50-Admin Core-Harris/Garb
P50-Admin Core-Harris/Garb
批准号:
10703371
负责人:
John E Harris
金额:
$21.24万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-09-12 至 2027-06-30
关键词:
AchievementAdvisory CommitteesAffectAtopic DermatitisAutoimmune DiseasesAutoimmunityBudgetsCaregiversCell Culture TechniquesCellsCenter for Translational Science ActivitiesClinical ResearchCollaborationsCommunicationCommunitiesComplexDataDermatologistDiseaseDisputesEducationEnsureEvaluationEventFDA approvedFundingGeneral PopulationGenerationsGenetic RiskGoalsGrantHumanHuman ResourcesImmunologistIndividualInformation DisseminationInstitutionInsulin-Dependent Diabetes MellitusKnowledgeLeadershipLeftMapsModelingMultiple SclerosisNatureOccupational activity of managing financesOutcomeParticipantPathogenesisPatientsPhysiciansPopulationProgress ReportsPsoriasisPublicationsResearchResearch PersonnelResolutionResourcesRheumatoid ArthritisSamplingScheduleScientific Advances and AccomplishmentsScientistSignal PathwaySignal TransductionSkinSystemT-Cell ReceptorT-LymphocyteTissuesTranslational ResearchUnited States National Institutes of HealthVitiligoWhite SpotsWorkloadchemokineclinical carecollaborative environmentexperiencehealth disparityimprovedinnovationinsightinterdisciplinary approachmeetingsmultidisciplinarymultiple omicsneoantigensoutreachoutreach programpsychologicresearch studyrisk variantsingle-cell RNA sequencingskin disorderskin lesionsuccesstooltranscriptomicstreatment strategy
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Over 70 million individuals worldwide suffer from vitiligo, a psychologically devastating autoimmune disease of
the skin that causes disfiguring white spots and disproportionately affects those with darker skin. This, com-
bined with a lack of FDA-approved treatments for vitiligo, creates a concerning health disparity for some of the
most vulnerable of our population. Because of the accessibility of the skin, vitiligo provides a unique oppor-
tunity for detailed, innovative translational research studies that provide insight into its pathogenesis and lead
to improved treatment strategies. Further, vitiligo shares genetic risk alleles and other mechanisms with auto-
immune diseases that are more complex and/or difficult to study using translational tools and thus provides an
unparalleled model through which to understand mechanisms of human autoimmunity.
We have generated preliminary data using a translational multi-omics approach that reveal thousands of new
data points marking hundreds of new signaling pathways that coordinate autoimmunity in the skin during viti-
ligo. What remains lacking, however, is an integrated, multidisciplinary approach to assemble this new data
into a comprehensive understanding of disease pathogenesis within vitiligo skin lesions. Thus, there is a critical
need to establish a coordinated, collaborative effort to reveal new, high-resolution insight into the pathogenesis
of vitiligo and other autoimmune diseases that could support innovative, advanced treatment strategies.
We will leverage our existing data, leading multidisciplinary investigative team, and cutting-edge research tools
to accomplish this task within the Vitiligo Center of Research Translation (VCORT). Strong communication,
coordination, fiscal management, education, and dissemination of information will be critical to the success of
this multidisciplinary effort. The overall objective of the Administrative Core is to serve as an interface among
VCORT participants to promote the generation and dissemination of knowledge among the collaborative inves-
tigators, the broader scientific community, and the public. We will do this through the following specific
aims: 1) Manage internal and external communication; 2) Advance scientific endeavors and ensure achieve-
ment of specific milestones; 3) Effectively manage financial resources and ensure compliance. Thus, the Core
will remove administrative and financial duties from the workload of VCORT scientists, allowing them to focus
on research.
The expected outcome is to have established and maintained a VCORT through which exceptional transla-
tional science is conducted in a diverse, informed, and highly collaborative environment. This will have an im-
portant positive impact on patients, caregivers, and the research community through progress toward under-
standing and treating vitiligo, as well as establishing strong collaborations to expand the field of translational
research in vitiligo and human autoimmunity.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Dissecting Functional Autoimmunity through High-Resolution Multiomics in a Vitiligo Center of Research Translation (V-CoRT)
-
批准号:10404442
-
项目类别:
-
资助金额:$167.9万
-
财政年份:2022
-
负责人:John E Harris
-
依托单位:
High Resolution Spatial Transcriptomics using seq-FISH+
-
批准号:10703380
-
项目类别:
-
资助金额:$36.4万
-
财政年份:2022
-
负责人:John E Harris
-
依托单位:
P50-Admin Core-Harris/Garb
-
批准号:10404443
-
项目类别:
-
资助金额:$21.24万
-
财政年份:2022
-
负责人:John E Harris
-
依托单位:
Dissecting Functional Autoimmunity through High-Resolution Multiomics in a Vitiligo Center of Research Translation (V-CoRT)
-
批准号:10703370
-
项目类别:
-
资助金额:$166.21万
-
财政年份:2022
-
负责人:John E Harris
-
依托单位:
High Resolution Spatial Transcriptomics using seq-FISH+
-
批准号:10404444
-
项目类别:
-
资助金额:$38.09万
-
财政年份:2022
-
负责人:John E Harris
-
依托单位:
Treg Migration and Function During Autoimmunity within Peripheral Tissue
-
批准号:9979628
-
项目类别:
-
资助金额:$36.85万
-
财政年份:2015
-
负责人:John E Harris
-
依托单位:
Treg Migration and Function During Autoimmunity within Peripheral Tissue
-
批准号:9753126
-
项目类别:
-
资助金额:$36.85万
-
财政年份:2015
-
负责人:John E Harris
-
依托单位:
Treg Migration and Function During Autoimmunity within Peripheral Tissue
-
批准号:9322541
-
项目类别:
-
资助金额:$36.85万
-
财政年份:2015
-
负责人:John E Harris
-
依托单位:
Treg Migration and Function During Autoimmunity within Peripheral Tissue
-
批准号:9984020
-
项目类别:
-
资助金额:$0.1万
-
财政年份:2015
-
负责人:John E Harris
-
依托单位:
Treg Migration and Function During Autoimmunity within Peripheral Tissue
-
批准号:9539195
-
项目类别:
-
资助金额:$36.85万
-
财政年份:2015
-
负责人:John E Harris
-
依托单位:
Targeting IFN gamma and chemokines to treat vitiligo in a humanized mouse model
-
批准号:8883383
-
项目类别:
-
资助金额:$12.37万
-
财政年份:2011
-
负责人:John E Harris
-
依托单位:
Targeting IFN gamma and chemokines to treat vitiligo in a humanized mouse model
-
批准号:8165781
-
项目类别:
-
资助金额:$12.37万
-
财政年份:2011
-
负责人:John E Harris
-
依托单位:
Targeting IFN gamma and chemokines to treat vitiligo in a humanized mouse model
-
批准号:8502440
-
项目类别:
-
资助金额:$12.37万
-
财政年份:2011
-
负责人:John E Harris
-
依托单位:
Targeting IFN gamma and chemokines to treat vitiligo in a humanized mouse model
-
批准号:8707973
-
项目类别:
-
资助金额:$12.37万
-
财政年份:2011
-
负责人:John E Harris
-
依托单位:
Targeting IFN gamma and chemokines to treat vitiligo in a humanized mouse model
-
批准号:8786278
-
项目类别:
-
资助金额:$0.08万
-
财政年份:2011
-
负责人:John E Harris
-
依托单位:
Targeting IFN gamma and chemokines to treat vitiligo in a humanized mouse model
-
批准号:8301570
-
项目类别:
-
资助金额:$12.37万
-
财政年份:2011
-
负责人:John E Harris
-
依托单位:
海外基金